Compared to previous studies aimed at studying EGFR-TKI resistance in EGFR-mutant lung cancer, our study evaluated EGFR-TKI resistance from the perspective that the interaction between tumor and immune cells influences the TKI effect, rather than an analysis of tumor cells alone. The gene discussed is EGFR; the disease is lung cancer.